Virtual Journal Club – ThyGeNEXT / ThyramiR: Utilizing “Markers that Matter” to assist in the Risk Assessment of Thyroid Nodules
Posted on
Alidad Mireskandari, Ph.D., Head of Product Development, Endocrine Business Unit at Interpace Diagnostics brings us a presentation, case studies and a Q&A.